Producers Online
HOUSTON, March 17, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today the appointment of Katherine Motlagh to its board of directors. Ms. Motlagh’s appointment is…
– Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to robust long-term clinical responses and was well tolerated; Phase…
CONWAY, Ark., March 17, 2025 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NYSE: HOMB), parent company of Centennial Bank, today announced it expects to release First Quarter 2025 earnings after the…
AUSTIN, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) (the “Company”), a leading provider of pawn loans in the United States and Latin America, announced today that…
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International.…
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient marketAcquisition advances Paratek’s vision to become a multi-product…
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market Amsterdam, 20 March 2025 – Arcadis, a global leader in intelligence-driven sustainable design, engineering, and…
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma AB’s (“Xbrane”) R&D operations…
Notification of transaction by a closely associated person of a Director of Millicom (Tigo) Luxembourg, March 17, 2025 – Millicom International Cellular S.A. ("Millicom") announces that, on March 14, 2025,…
Alvotech (NASDAQ: ALVO) tilkynnti í dag að fyrirtækið hafi keypt þróunarstarfsemi sænska líftæknifyrirtækisins Xbrane Biopharma AB (“Xbrane”). Með kaupunum eykur Alvotech afkastagetu sína í þróun nýrra líftæknilyfjahliðstæða, styrkir stöðu sína…